Stock Ratings / Health Care / UFPT / earnings

INSP (61) LMAT (74) XRAY (46) KMTS (43) ⌘ Pro Terminal →

UFP Technologies Inc. (UFPT) Next Earnings Date & Expected ±7% Move

$293.30 +2.55% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $295.35

UFP Technologies Inc. (UFPT) earns a Roarable Rating of A- (Buy) with 81/100 RQD Confidence. High-quality cash engine (28% profit margin, 14% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

📊 Historical Track Record: Scores of 81/100 (A-) historically ranked in the Top 8% of excess returns over the next 90 days (+8.4% avg 90D alpha vs SPY • 71.6% hit rate) →

ROARABLE A- • BUY Cap $2.27B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $295.35 (+0.70%)🧬 Cannibal Buyback (-2.08% YoY Shares)⚙️ Cash Engine: 17/20 (A-) • 15.2% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 81/100 (A-) historically ranked in the Top 8% of excess returns over the next 90 days (+8.4% avg 90D alpha vs SPY • 71.6% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERBUY • A-

3-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B+ · Rk A

Each axis scored 0–20

12M PRICE TARGET CONE+10.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for UFPT)Realized 20D OHLCV Swing Band: ±7%

Deterministic 5-Pillar Attribution (81/100 Composite)

🔍 WHY UFPT SCORES 81/100 (A-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (22% of score)

Altman Z-Score 8.31 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 9/9

▲ #2 Bullish Driver: Cash Engine Quality+17/20 pts (21% of score)

SEC XBRL FY 2025 (10-K): 15.2% FCF Margin ($91.9M FCF) & 28.3% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning14/20 pts (-6 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-6 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade B$288.97+0.9% Next Q

Q2 (-2Q)

Grade B+$291.67+1.4% Next Q

Q3 (-1Q)

Grade A-$295.78-0.8% Next Q

Current

Grade A-$293.30+8.4% Hist 90D α

Trajectory: B (73) → A- (81)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the UFPT Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 81/100 (A-) score, UFPT faces multiple-compression risk if 33.3x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.08% YoY Shares) — any gross margin slip below 25.8% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($291.73) or 200D SMA ($249.26) invalidates the momentum regime and cuts Target Base ($323.66) toward Bear Floor ($240.51).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $UFPT• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “UFPT Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 81%NO 19%Trade / Inspect Odds →

NEXT EST. WINDOW: Dec 30, 2026 (~58 DAYS)

Historical OHLCV Volatility ±7% Swing Band

±$20.53 Expected Swing

MODEL EARNINGS SETUP GAUGE

UFPT Quantitative Pre-Earnings Setup: 81/100

Trailing EPS: $8.82 • YoY Revenue Growth: 19.5%

Model Bullish Setup (81/100)Model Risk Weight (19/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

Period	Filed	Revenue	Net Profit	Free Cash Flow	Gross Margin
FY 2025	2025-12-31	$602.8M	$68.3M	$91.9M	28.3%
FY 2024	2024-12-31	$504.4M	$59.0M	$56.9M	29.1%
FY 2023	2023-12-31	$400.1M	$44.9M	$41.3M	28.3%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating UFPT & AI Leaders Without Chasing Tops

✓Institutional whale strikes & implied earnings move audit on UFPT
✓How disciplined traders manage risk using pre-published trigger & invalidation levels
✓Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

UFPT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +53.06%⚡ TESTING RESISTANCE

2026-10-30O $289.8H $293.3L $279.8C $293.3VOL 85.1K

RES: $298.5SUP: $278.1SMA50: $291.7SMA200: $249.3

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

UFPT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 UFPT Butterfly Map → + Track UFPT →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

25.7%/yr Implied 5Y Growth

vs. +19.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on UFPT today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for UFPT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for UFPT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (UFPT)

Health Care Rank #15 of 1016 ⚔️ INSP vs UFPT Full Matrix →

1. Head-to-Head Health Care Peer Comparison (UFPT vs. INSP, LMAT, XRAY, KMTS)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, UFP Technologies Inc. (UFPT) ranks #15 by composite RQD confidence (81/100, grade A-) and #238 by equity capitalization ($2.27B). Within this direct 5-issuer industry benchmark cohort, INSP leads on earnings valuation at 14.2x trailing P/E, while LMAT leads on capital efficiency and profitability with 14.7% ROIC and 71.5% gross margin. UFPT currently leads its immediate peer cohort in composite quantitative strength at 81/100 (A-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
UFPT ACTIVE UFP Technologies Inc.	A-	81/100	33.3x	28.3%	13.9%	+2.55%	$2.27B	Benchmark Subject
INSP Inspire Medical Systems Inc.	C-	61/100	14.2x	85.4%	6.0%	+0.30%	$2.06B	/insp-vs-ufpt →
LMAT LeMaitre Vascular Inc.	B	74/100	33.8x	71.5%	14.7%	+2.90%	$1.95B	/lmat-vs-ufpt →
XRAY DENTSPLY SIRONA Inc.	D	46/100	—	50.0%	-11.0%	+1.80%	$1.92B	/xray-vs-ufpt →
KMTS Kestra Medical Technologies Ltd.	D-	43/100	—	51.4%	-35.0%	+2.48%	$1.82B	/kmts-vs-ufpt →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000914156

In its most recent audited fiscal period (FY2025, filed 2025-12-31), UFP Technologies Inc. (UFPT) reported GAAP revenue of $602.8M (+19.5% vs. FY2024 revenue of $504.4M , and +50.7% cumulative change since FY2023) , GAAP net income of $68.3M, operating cash flow of $91.9M, and free cash flow of $91.9M (+61.4% YoY). On the balance sheet, UFPT closed FY2025 with $655.1M in total assets against $123.0M in total debt (Altman Z-Score: 8.31, Piotroski F-Score: 9/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$602.8M	$68.3M	$91.9M	$91.9M	$655.1M	$123.0M
FY2024 (FY)	2024-12-31	$504.4M	$59.0M	$66.6M	$56.9M	$629.0M	$176.9M
FY2023 (FY)	2023-12-31	$400.1M	$44.9M	$41.3M	$41.3M	—	—

3. UFPT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is UFPT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, UFP Technologies Inc. (NASDAQ: UFPT) is rated A- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 81/100 at a spot price of $293.30 (+2.55% 1D, market cap $2.27B). Pillar breakdown: Fundamental Cash Engine 17/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 17/20, and SEC Balance-Sheet Forensics 15/20. Across 1016 tracked Health Care issuers, UFPT ranks #15 in composite RQD confidence.

How does UFPT compare to INSP and LMAT in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), UFPT carries a Roarable A- (81/100 RQD), trailing P/E of 33.3x, gross margin of 28.3%, and ROIC of 13.9%. By comparison, INSP (Inspire Medical Systems Inc.) holds a C- grade (61/100 RQD, P/E 14.2x, ROIC 6.0%, cap $2.06B) and LMAT (LeMaitre Vascular Inc.) posts a B grade (74/100 RQD, P/E 33.8x, ROIC 14.7%, cap $1.95B). Among the 5-stock peer group, INSP leads on earnings multiple (14.2x) while LMAT leads on capital efficiency (14.7% ROIC).

What are the biggest fundamental strengths and SEC risk factors for UFPT?

Per UFPT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000914156), UFP Technologies Inc. generated $602.8M in revenue (+19.5% YoY), $68.3M in net income, and $91.9M in free cash flow against $655.1M in total assets and $123.0M in total debt. Key quantitative strengths: Strong cash generator (28% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is UFPT trading relative to its 50-day, 200-day, and 52-week technical levels?

UFPT last traded at $293.30 (+2.55% on volume of 107,557 shares), positioning the stock +0.54% above its 50-day simple moving average ($291.73) and +17.67% above its 200-day simple moving average ($249.26). Across its 52-week range of $173.86 to $338.71, UFPT sits at the 72.5% percentile with a 14-day RSI of 44.0 (NEUTRAL RANGE) and an implied next-earnings move of ±7.0% ($272.77 to $313.83).